Sponsor pipeline

Nathalie Levasseur clinical trial pipeline

Get alerts when Nathalie Levasseur's trials change

1 active trials 1 recruiting 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07299409 First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer… Advanced Triple Negative Breast Cancer Recruiting 2026-10-06

Disease areas by active trials

Breast Cancer (1) · Triple-Negative Breast Cancer (1)

Get alerts when Nathalie Levasseur's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free